A detailed history of Rothschild Investment LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Rothschild Investment LLC holds 9,302 shares of LLY stock, worth $6.96 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
9,302
Previous 9,437 1.43%
Holding current value
$6.96 Million
Previous $8.54 Billion 3.55%
% of portfolio
0.54%
Previous 0.59%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$772.14 - $960.02 $104,238 - $129,602
-135 Reduced 1.43%
9,302 $8.24 Billion
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $6.84 Million - $8.58 Million
9,437 New
9,437 $8.54 Billion
Q1 2024

Jul 31, 2024

BUY
$592.2 - $792.28 $151,603 - $202,823
256 Added 2.91%
9,046 $7.04 Billion
Q4 2023

Jul 31, 2024

SELL
$525.19 - $619.13 $339,797 - $400,577
-647 Reduced 6.86%
8,790 $5.12 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.